Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-099168
Filing Date
2024-08-20
Accepted
2024-08-20 16:45:02
Documents
1
Period of Report
2024-08-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2959
  Complete submission text file 0000950170-24-099168.txt   4365
Mailing Address 7 RAPPS RUN DRIVE MALVERN PA 19355
Business Address
Sorensen Mel (Reporting) CIK: 0001444783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 241225853

Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)